Preprint · Jul 29, 2026
Estrogen and modifiable risk factors for dementia: an analysis of the EPAD LCS dataset
By Gregory MS
Female sex is recognised as a risk factor for Alzheimer’s disease and related dementias (ADRD), with higher incidence and risk observed in women. Previous research suggests that females experience faster hippocampal atrophy and greater tau accumulation, potentially due to decreasing steroid hormone levels. There are three main forms of oestrogen (oestradiol, estrone, estriol), which occur in both women and men, but are at higher concentrations in women. Oestradiol is the main form of oestrogen in child-bearing women and a major target of hormone replacement therapies, whilst estrone is the main form of oestrogen post-menopause, and estriol is most important during pregnancy. Oestrogen levels tend to be more stable across a man’s life course, with declines in concentrations typically more gradual than are seen in female menopause. There are a growing number of identified modifiable risk factors for dementia, as outlined by the Lancet Commission on Dementia Prevention, Intervention and Care. In addition, the APOEε4 gene is a known genetic risk factor for AD, and research suggests there may be important interactions between this gene and oestrogen. This project will investigate the link between these modifiable dementia risk factors (where available in the selected dataset), and APOEε4, and three forms of oestrogen within a European cohort at risk for dementia. By exploring the relationship between steroid hormones and dementia risk, this project aims to advance our understanding of potential prevention strategies.